Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1993 2
1999 2
2000 3
2001 1
2003 1
2004 7
2005 3
2006 1
2007 2
2008 1
2010 1
2011 1
2014 6
2015 4
2016 5
2017 4
2018 5
2019 2
2020 3
2021 8
2022 4
2023 4
2024 4
2025 5
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).
Hanauer SB, Sands BE, Schreiber S, Danese S, Kłopocka M, Kierkuś J, Kulynych R, Gonciarz M, Sołtysiak A, Smoliński P, Srećković S, Valuyskikh E, Lahat A, Horyński M, Gasbarrini A, Osipenko M, Borzan V, Kowalski M, Saenko D, Sardinov R, Lee SJ, Kim S, Bae Y, Lee S, Lee S, Lee JH, Yang S, Lee J, Lee J, Kim JM, Park G, Sandborn WJ, Colombel JF. Hanauer SB, et al. Among authors: klopocka m. Gastroenterology. 2024 Oct;167(5):919-933. doi: 10.1053/j.gastro.2024.05.006. Epub 2024 May 23. Gastroenterology. 2024. PMID: 38788861 Free article. Clinical Trial.
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study.
Danese S, Klopocka M, Scherl EJ, Romatowski J, Allegretti JR, Peeva E, Vincent MS, Schoenbeck U, Ye Z, Hassan-Zahraee M, Rath N, Li G, Neelakantan S, Banfield C, Lepsy C, Chandra DE, Hung KE. Danese S, et al. Among authors: klopocka m. Clin Gastroenterol Hepatol. 2021 Nov;19(11):2324-2332.e6. doi: 10.1016/j.cgh.2021.06.011. Epub 2021 Jun 12. Clin Gastroenterol Hepatol. 2021. PMID: 34126262 Clinical Trial.
Clinical nutrition in gastrointestinal diseases: an up-to-date clinical practice guideline.
Sobocki J, Bogdanowska-Charkiewicz D, Budnicka-Borkowicz A, Chełmicka M, Dudkowiak R, Guzek M, Kaczka A, Kanikowska A, Kurek K, Matysiak K, Paluch J, Szewczuk M, Walecka-Kapica E, Adrych K, Dąbrowski A, Gąsiorowska A, Hartleb M, Kłopocka M, Talar-Wojnarowska R, Waśko-Czopnik D, Mańkowska-Wierzbicka D. Sobocki J, et al. Among authors: klopocka m. Pol Arch Intern Med. 2025 Mar 24;135(3):16967. doi: 10.20452/pamw.16967. Epub 2025 Feb 28. Pol Arch Intern Med. 2025. PMID: 40035369 Free article.
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
Hassan-Zahraee M, Ye Z, Xi L, Baniecki ML, Li X, Hyde CL, Zhang J, Raha N, Karlsson F, Quan J, Ziemek D, Neelakantan S, Lepsy C, Allegretti JR, Romatowski J, Scherl EJ, Klopocka M, Danese S, Chandra DE, Schoenbeck U, Vincent MS, Longman R, Hung KE. Hassan-Zahraee M, et al. Among authors: klopocka m. Inflamm Bowel Dis. 2022 Mar 2;28(3):434-446. doi: 10.1093/ibd/izab193. Inflamm Bowel Dis. 2022. PMID: 34427649 Free PMC article.
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial.
Jairath V, Zou G, Wang Z, Adsul S, Colombel JF, D'Haens GR, Freire M, Moran GW, Peyrin-Biroulet L, Sandborn WJ, Sebastian S, Travis S, Vermeire S, Radulescu G, Sigler J, Hanžel J, Ma C, Sedano R, McFarlane SC, Arya N, Beaton M, Bossuyt P, Danese S, Green D, Harlan W 3rd, Horynski M, Klopocka M, Petroniene R, Silverberg MS, Wolanski L, Feagan BG. Jairath V, et al. Among authors: klopocka m. BMJ Open Gastroenterol. 2024 Feb 8;11(1):e001218. doi: 10.1136/bmjgast-2023-001218. BMJ Open Gastroenterol. 2024. PMID: 38336367 Free PMC article.
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY).
Colombel JF, Sandborn WJ, Schreiber S, Danese S, Kłopocka M, Kierkuś J, Kulynych R, Gonciarz M, Sołtysiak A, Smoliński P, Srećković S, Valuyskikh E, Lahat A, Horyński M, Gasbarrini A, Osipenko M, Borzan V, Kowalski M, Saenko D, Sardinov R, Lee SJ, Kim S, Bae Y, Lee S, Lee S, Lee JH, Kim JM, Park G, Lee J, Lee J, Ryu JY, Sands BE, Hanauer SB. Colombel JF, et al. Among authors: klopocka m. J Crohns Colitis. 2025 Jun 4;19(6):jjaf060. doi: 10.1093/ecco-jcc/jjaf060. J Crohns Colitis. 2025. PMID: 40243842 Free PMC article. Clinical Trial.
Efficacy of Upadacitinib Induction Treatment in Moderate-to-Severe Ulcerative Colitis Including Intestinal Ultrasound Assessment: A Multicenter, Real-World Observational Study.
Kaniewska M, Lewandowski K, Krogulecki M, Filipiuk A, Gonciarz M, Pietrzak A, Janiak M, Adrych K, Klufczynska A, Piotrowicz G, Kopertowska-Majchrzak M, Panasiuk A, Mahadea D, Eder P, Tarasiuk A, Rosołowski M, Talar-Wojnarowska R, Małecka-Wojciesko E, Liebert A, Kłopocka M, Walecka-Kapica E, Gąsiorowska A, Galińska B, Leśniakowski K, Zwolińska-Wcisło M, Naumowicz A, Daniluk J, Rydzewska G. Kaniewska M, et al. Among authors: klopocka m. J Clin Med. 2025 Mar 3;14(5):1695. doi: 10.3390/jcm14051695. J Clin Med. 2025. PMID: 40095725 Free PMC article.
Profile of homeless people in emergency departments.
Burak AM, Wyszkowska Z, Liebert A, Kłopocka M. Burak AM, et al. Among authors: klopocka m. Int J Occup Med Environ Health. 2022 Apr 11;35(2):157-167. doi: 10.13075/ijomeh.1896.01842. Epub 2021 Sep 22. Int J Occup Med Environ Health. 2022. PMID: 34569553 Free PMC article.
75 results